|Bid||100.46 x 900|
|Ask||106.00 x 1100|
|Day's Range||103.59 - 106.41|
|52 Week Range||88.50 - 187.90|
|Beta (5Y Monthly)||1.40|
|PE Ratio (TTM)||3.27|
|Earnings Date||Oct 19, 2022 - Oct 24, 2022|
|Forward Dividend & Yield||2.00 (1.89%)|
|Ex-Dividend Date||Sep 29, 2022|
|1y Target Est||122.42|
Subscribe to Yahoo Finance Plus to view Fair Value for NUE
The market's drop reverberated through the portfolio -- with our inverse-ETF positions helping blunt declines. Amid our moves, we exited Morgan Stanley and entered Elevance Health.
Nucor (NUE) closed at $108.85 in the latest trading session, marking a -1.49% move from the prior day.
Nucor (NUE) is well positioned to outperform the market, as it exhibits above-average growth in financials.